Adequate Intake Is Not An RDA: The Three Rows Built On A Different Reference

Two kinds of number on one panel

The Gelagen supplement facts page on this website states a reference figure beside each of the thirteen printed amounts, and if you read those thirteen sentences closely, they do not all use the same word. Ten of them say "RDA," the Recommended Dietary Allowance. Three of them say "Adequate Intake" instead: biotin, pantothenic acid and choline. Inositol uses neither, because no reference of any kind has been set for it.

Most readers skim past this distinction, and most of the time it costs nothing to skim past it, because both an RDA and an Adequate Intake are printed the same way, as a milligram or microgram figure with a percentage beside it. But the two numbers are not built the same way, and the difference is not a technicality. It is the difference between a target derived from a measured population requirement and a target derived from an educated estimate of what healthy people already eat.

How an RDA gets built

The modern framework behind every reference number on a US nutrition label comes from the Institute of Medicine's Dietary Reference Intakes project, described in detail by Yates, Schlicker and Suitor in a 1998 paper explaining the new approach as it applied to calcium, the B vitamins and choline. According to that paper, the DRI system actually contains four separate reference values, not one, and understanding an RDA means understanding all four together.

The starting point is the Estimated Average Requirement, or EAR: the intake level at which, going by the available data, the needs of half the people consuming it will not be met. An EAR is a population statistic built from studies that directly measure how much of a nutrient a group of people need, using indicators such as blood levels, balance studies or biochemical markers of adequacy. Once an EAR exists, the RDA is calculated from it by adding a margin, generally set so that the RDA covers the needs of nearly all healthy individuals in a life-stage and sex group, not just half of them. A fourth reference, the Tolerable Upper Intake Level, is set from a separate line of evidence about the amount at which harm becomes possible.

The important detail is the order of operations: an RDA cannot exist without an EAR first, and an EAR requires evidence good enough to describe a full distribution of requirement across a population, not just a rough sense of what people typically consume.

How an Adequate Intake gets built, and why

For some nutrients, that evidence does not exist, or did not exist when the relevant DRI report was written. In those cases, the committee sets an Adequate Intake instead. Yates and colleagues describe it directly: the AI is "a level judged by the experts developing the reference intakes to meet the needs of all individuals in a group, but which is based on much less data and substantially more judgment than that used in establishing an EAR and subsequently the RDA." Their paper states the rule plainly: "When an RDA cannot be set, an AI is given."

In practice, an AI is typically built from observed intake data: what apparently healthy people, studied under normal conditions, are seen to consume of a given nutrient, on the assumption that if a population shows no signs of deficiency at that level, the level is probably adequate. This is a genuinely different kind of evidence from an EAR. An EAR asks how much of a nutrient a body needs, measured directly. An AI more often asks how much healthy people already get, then treats that figure as a reasonable stand-in for a requirement nobody has been able to measure with confidence.

Both an RDA and an AI are described in the same 1998 paper as "goals for an individual," so neither is meant to be read as a looser or more optional number in everyday use. The difference lies entirely in how much confidence sits behind the figure, not in how it should be used day to day.

The three AI rows on this label

This website's own panel page already states, in its own reference column, which of the thirteen Gelagen rows fall into which category, even though it does not name the distinction directly. Three rows are described with the words "Adequate Intake":

All three of these happen to be nutrients the 1998 Institute of Medicine report by Yates and colleagues specifically covered, alongside calcium, the B vitamins and choline as a group, which is not a coincidence: biotin, pantothenic acid and choline were, at the time the modern DRI framework was built, three of the nutrients for which the available evidence did not clear the bar needed to calculate a full EAR and RDA. The remaining ten rows on this panel, from vitamin A through zinc, all carry a stated RDA instead, meaning the committee that reviewed each of them judged the underlying evidence sufficient to describe a population requirement directly.

Biotin in more detail: a coenzyme without a fixed requirement number

Biotin is the largest single figure on the Gelagen panel by a wide margin, at 5,000 mcg against a 30 mcg reference, and it is worth understanding why a nutrient this central to the product's own framing is also the one with the least precisely measured requirement. A 2009 review by Zempleni, Wijeratne and Hassan describes biotin as a water-soluble vitamin that serves as a coenzyme for five carboxylase enzymes in humans, and that is also covalently attached to specific lysine residues in histone proteins, a modification that affects chromatin structure and plays a role in gene regulation. The review covers biotin's metabolism, the proteins responsible for its handling in the body, including holocarboxylase synthetase, biotinidase, and the transporters SMVT and MCT1, and the markers researchers use to assess biotin status.

What that review does not describe is a single, well-validated threshold at which biotin intake reliably produces deficiency in an otherwise healthy adult eating a normal diet, and true dietary biotin deficiency is understood to be rare outside specific circumstances such as prolonged raw egg-white consumption, certain inherited metabolic disorders, or particular drug interactions, all of which the review discusses. That is precisely the situation the Adequate Intake framework was designed for: a nutrient whose biological role is well characterized, but whose population requirement has not been pinned down by the kind of dose-response data an EAR needs. The 30 mcg figure on this panel is a reasonable, judgment-based estimate built the way Yates and colleagues describe, not a number derived from experiments that titrated intake against a measured shortfall.

Why a percent Daily Value can still be printed against an AI

A reasonable question at this point is why the Gelagen panel, and nutrition labels generally, can print a percent Daily Value for biotin, pantothenic acid and choline at all, if the underlying reference is built on less certain footing than an RDA. The answer is that the FDA's Daily Value figures used on labels, set out in 21 CFR 101.9, are drawn from whichever of the DRI reference values is available and appropriate for labeling purposes, RDA or AI, and the regulation does not require the stronger of the two before allowing a percentage to be printed. For biotin, pantothenic acid and choline, the Daily Value used on labels is numerically the same as the Adequate Intake figure the 1998 report set: 30 mcg, 5 mg and 550 mg respectively, matching exactly what the panel page states.

So the percentage printed for these three rows is arithmetically identical in form to the percentage printed for the ten RDA-based rows. What differs is only what sits behind the reference number being divided into, and that difference does not show up anywhere on the label itself. A shopper comparing "167 times the Daily Value" for biotin against "70% of the Daily Value" for vitamin A has no way, from the percentages alone, to know that one denominator rests on a fuller evidence base than the other.

What "no RDA" does not mean

It would be a mistake to read any of this as a safety concern, and nothing in the framework Yates and colleagues describe suggests one. An Adequate Intake is not a lower-confidence warning that a nutrient might be risky; it is a lower-confidence statement about how precisely a requirement has been measured. Biotin, pantothenic acid and choline are not unusual or poorly studied nutrients in general; they are simply nutrients for which the specific kind of evidence needed to compute a full Estimated Average Requirement, evidence describing a distribution of individual requirement across a population, was not available or sufficient at the time the relevant DRI report was written.

It is also not a statement that the printed amount is somehow arbitrary. The 5,000 mcg of biotin on this panel is 167 times the 30 mcg Adequate Intake, and that multiple is real and large regardless of which kind of reference the 30 mcg happens to be. The AI-versus-RDA distinction changes how confidently the reference figure itself can be interpreted as "the amount a healthy population needs." It does not change the arithmetic of comparing a printed amount to that reference, and it says nothing at all about whether a given dose is safe, which is a separate question governed by the Tolerable Upper Intake Level where one has been set.

The other ten rows: how their RDA figures were set

The ten remaining rows on the Gelagen panel, vitamin A, vitamin C, vitamin D, vitamin E, vitamin B6, folate, vitamin B12, iodine and zinc, all carry a stated RDA on this website's own panel page, meaning each was judged to have evidence sufficient for a full EAR-to-RDA calculation by the relevant Institute of Medicine or National Academies committee. The broader DRI framework these RDAs sit inside is described across several reports; a companion 2002 report by Trumbo and colleagues, covering energy and macronutrients rather than vitamins and minerals, documents that the same four-part structure, EAR, RDA, AI and UL, was applied consistently across every nutrient category the DRI project addressed, not only the micronutrients this panel is built from.

That consistency matters for a simple reason: it means the RDA-versus-AI split on this panel is not a quirk of biotin, pantothenic acid and choline specifically. It is the same evidentiary distinction, applied by the same committees using the same rules, that runs across the entire US system of nutrient reference values, food and supplement labels included.

How to tell which is which on any label

The distinction is not printed on a Supplement Facts panel, so checking it means going outside the label itself.

• Note the nutrient and the reference figure printed, then look up whether the National Academies' current Dietary Reference Intake tables list that figure as an RDA or an AI for your life stage. The two are usually tabulated side by side in the same reference document.
• Remember that an AI is most common for nutrients where population requirement data is thin: biotin, pantothenic acid, choline, and several others not on this panel, including vitamin K and manganese.
• Do not read an AI as a softer number to hit. Both figures are described as individual goals in the DRI framework, and treating an AI as optional has no basis in how the reference was designed to be used.
• Separately, check whether a Tolerable Upper Intake Level has been set for that nutrient. An AI and a UL are independent questions; a nutrient can have a well-established upper limit even where its lower reference is an AI rather than an RDA, or, as with pantothenic acid and biotin, no upper limit at all.

Reading a label this carefully is more than most people do, and it is not necessary for ordinary use of a dietary supplement. But for the three rows on this panel where the reference figure is an estimate built from observed healthy intake rather than a measured requirement, knowing that distinction exists is the difference between reading the percentage as a precise fraction of a known need and reading it, more accurately, as a fraction of the best estimate currently available.

Related reading on this journal. See also how the percentage beside each of these figures gets rounded before it is printed and what a Daily Value is measured against in the first place. The full printed panel is on the supplement facts page.

Sources for this article

Sourced from the product label and PubMed-indexed research. Every ingredient amount above is read from the Gelagen supplement facts page. Every study is listed with its PubMed number, and no claim here goes beyond what those records state.